Please login to the form below

Not currently logged in
Email:
Password:

BIND Biosciences

This page shows the latest BIND Biosciences news and features for those working in and with pharma, biotech and healthcare.

Amgen signs $180m nanotechnology cancer deal

Amgen signs $180m nanotechnology cancer deal

Amgen signs $180m nanotechnology cancer deal. Will combine BIND Biosciences' tissue-targeting technology with a molecularly-targeted drug. ... Amgen has teamed up with nanotechnology specialist BIND Biosciences to develop a new version of one of its

Latest news

More from news
Approximately 1 fully matching, plus 0 partially matching documents found.

Latest from PMHub

  • Use of biomarkers in marketing

    Mark Assenti is a Senior Associate Consultant at Blue Latitude. Mark began his career in the biosciences field, studying genetics at Cardiff University.

More from PMHub
Approximately 1 fully matching, plus 0 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Havas Life Medicom

We’re a specialist-led, unified communications agency delivering connected healthcare communications, informed through fresh insights, smart thinking and inspired ideas. Our...

Latest intelligence

OUTiCO win Best in UK Pharmaceutical Outsourcing award
The Corporate LiveWire Healthcare and Life Sciences Awards celebrate global companies and individuals who have excelled over the past 12 months....
artificial-intelligence-in-healthcare.jpg
Artificial Intelligence in Healthcare
Artificial intelligence is already out-diagnosing experts, but would you put a computer in charge of your healthcare? The good, the bad; we take a look....
World Pancreatic Cancer Day 2018: Combating misconceptions in pancreatic cancer
Patients diagnosed with pancreatic cancer face a dismal prognosis, with the disease having the lowest survival rate of all major cancers. In spite of this, pancreatic cancer research is chronically...

Infographics